MANGALAM DRUG & CHEM LTD (MANGALAM) financials

MANGALAM DRUG & CHEM LTD (MANGALAM) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1977, Mangalam Drugs & Organics Ltd manufactures Active Pharmaceutical Ingredients and Intermediates.[1]

Market Cap: ₹49.2Cr.
Current Price: ₹31.1
ROE: -34.8%
ROCE: -13.8%
Book Value: ₹65.3
Dividend Yield: 0.00%
52W High / Low: ₹73.0/22.7

In Jun 2026, MANGALAM DRUG & CHEM LTD (MANGALAM) reported sales ₹57.12 Cr and net profit ₹-7.55 Cr.

Annual TTM: sales ₹232 Cr, net profit ₹-38 Cr.

Shareholding: Promoters 35.65% (Sep 2026), FIIs 0.11% (Sep 2026), Public 64.24% (Sep 2026), No. of Shareholders 23,991% (Sep 2026).

MANGALAM quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	79.94	88.71	72.78	57.21	49.54	58.38	67.29	57.12
Expenses	71.25	79.94	62.88	61.86	52.37	59.96	72.65	56.22
Operating Profit	8.69	8.77	9.90	-4.65	-2.83	-1.58	-5.36	0.90
OPM %	10.87%	9.89%	13.60%	-8.13%	-5.71%	-2.71%	-7.97%	1.58%
Other Income	0.14	0.13	0.47	0.14	0.03	0.22	0.09	0.11
Interest	3.67	3.49	4.03	4.04	5.03	4.05	3.08	3.68
Depreciation	3.97	3.93	4.61	4.38	4.53	4.37	4.56	3.99
Profit before tax	1.19	1.48	1.73	-12.93	-12.36	-9.78	-12.91	-6.66
Tax %	-125.21%	5.41%	90.75%	6.19%	-41.42%	0.00%	1.16%	13.36%
Net Profit	2.69	1.40	0.15	-13.73	-7.25	-9.78	-13.06	-7.55
EPS in Rs	1.70	0.88	0.09	-8.67	-4.58	-6.18	-8.25	-4.77
Raw PDF	—	—	—	—	—	—	—	—

MANGALAM profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	282	380	451	372	369	318	232	232
Expenses	259	327	402	347	351	282	247	241
Operating Profit	24	53	49	26	17	36	-15	-9
OPM %	8%	14%	11%	7%	4.7%	11%	-6%	-3.8%
Other Income	1	5	0	0	0	1	1	0
Interest	10	9	11	13	14	15	16	16
Depreciation	8	9	10	11	15	16	18	17
Profit before tax	6	40	28	2	-11	5	-48	-42
Tax %	-32%	29%	29%	43%	-18%	-39%	-9%	—
Net Profit	8	28	20	1	-9	7	-44	-38
EPS in Rs	5.21	17.67	12.42	0.80	-5.72	4.37	-27.68	-23.78
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

MANGALAM balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	16	16	16	16	16	16
Reserves	80	88	115	135	136	127	133	87
Borrowings	65	52	70	88	89	107	96	113
Other Liabilities	50	75	64	90	117	108	114	92
Total Liabilities	211	231	264	328	358	357	359	308
Fixed Assets	103	101	118	135	142	147	156	148
CWIP	0	1	6	6	9	8	3	4
Investments	0	0	0	0	0	0	0	0
Other Assets	107	128	140	188	206	202	201	156
Total Assets	211	231	264	328	358	357	359	308

MANGALAM cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	22	31	28	26	38	12	43	4
Cash from Investing Activity	-9	-7	-31	-27	-22	-18	-19	-12
Cash from Financing Activity	-11	-23	3	3	-17	6	-22	6
Net Cash Flow	1	0	-1	1	-1	-0	2	-2
Free Cash Flow	12	24	-4	-2	16	-6	23	-8
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	223%	129%	69%	70%	148%	71%	121%	-30%

MANGALAM shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	50.30%	50.30%	50.30%	50.30%	35.64%	35.65%	35.65%	35.65%
FIIs	0.11%	0.47%	0.53%	0.11%	0.13%	0.32%	0.11%	0.11%
Public	49.58%	49.23%	49.16%	49.57%	64.22%	64.03%	64.24%	64.24%
No. of Shareholders	19,679	19,697	19,728	19,881	21,227	25,140	24,465	23,991

MANGALAM key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	28	52	52	38	46	28	45	63
Inventory Days	175	121	85	139	200	185	303	239
Days Payable	77	106	63	65	139	124	199	160
Cash Conversion Cycle	126	67	74	112	107	88	148	142
Working Capital Days	21	10	23	43	38	18	13	-54
ROCE %	2%	11%	27%	18%	6%	1%	8%	-14%

MANGALAMUpdated 18 Oct 2026, 1:30

Mangalam Drug & Chem Ltd

MANGALAMUpdated 18 Oct 2026, 1:30

Market Cap

₹49.2Cr.

Current Price

₹31.1

High / Low

₹73.0/22.7

ROE-34.8%

ROCE-13.8%

Book Value₹65.3

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1977, Mangalam Drugs & Organics Ltd manufactures Active Pharmaceutical Ingredients and Intermediates.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	87.46	3.41	90.94	0.02	3.42	-10.29	-7.29	-9.54	-6.03
Sep 2023	81.56	3.24	79.37	0.03	3.73	-4.75	-25.05	-3.56	-2.25
Dec 2023	97.34	3.31	90.36	0	3.62	0.05	-920	0.5	0.32
Mar 2024	102.24	3.95	90.54	0.05	3.86	3.94	9.9	3.55	2.24
Jun 2024	76.53	3.75	68.34	0.02	3.87	0.59	-355.93	2.68	1.69
Sep 2024	79.94	3.67	71.25	0.14	3.97	1.19	-125.21	2.69	1.7
Dec 2024	88.71	3.49	79.94	0.13	3.93	1.48	5.41	1.4	0.88
Mar 2025	72.78	4.03	62.88	0.47	4.61	1.73	90.75	0.15	0.09
Jun 2025	57.21	4.04	61.86	0.14	4.38	-12.93	6.19	-13.73	-8.67
Sep 2025	49.54	5.03	52.37	0.03	4.53	-12.36	-41.42	-7.25	-4.58
Dec 2025	58.38	4.05	59.96	0.22	4.37	-9.78	0	-9.78	-6.18
Mar 2026	67.29	3.08	72.65	0.09	4.56	-12.91	1.16	-13.06	-8.25
Jun 2026	57.12	3.68	56.22	0.11	3.99	-6.66	13.36	-7.55	-4.77

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	221	10	200	0	4	6	-2	6	4.66
Mar 2016	295	9	257	0	4	24	33	16	11.15
Mar 2017	299	10	252	0	5	31	29	22	14.08
Mar 2018	269	12	222	1	7	29	32	20	12.57
Mar 2019	228	9	218	0	7	-6	40	-8	-5.07
Mar 2020	282	10	259	1	8	6	-32	8	5.21
Mar 2021	380	9	327	5	9	40	29	28	17.67
Mar 2022	451	11	402	0	10	28	29	20	12.42
Mar 2023	372	13	347	0	11	2	43	1	0.8
Mar 2024	369	14	351	0	15	-11	-18	-9	-5.72
Mar 2025	318	15	282	1	16	5	-39	7	4.37
Mar 2026	232	16	247	1	18	-48	-9	-44	-27.68
TTM	232	16	241	0	17	-42	—	-38	-23.78

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	35.65%
FIIs	0.11%
Public	64.24%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	50.31%	0.1%	—	49.59%
Mar 2024	50.31%	0.26%	—	49.42%
Jun 2024	50.31%	0.21%	—	49.47%
Sep 2024	50.3%	0.11%	—	49.58%
Dec 2024	50.3%	0.11%	—	49.58%
Mar 2025	50.3%	0.47%	—	49.23%
Jun 2025	50.3%	0.53%	—	49.16%
Sep 2025	50.3%	0.11%	—	49.57%
Dec 2025	35.64%	0.13%	—	64.22%
Mar 2026	35.65%	0.32%	—	64.03%
Jun 2026	35.65%	0.11%	—	64.24%
Sep 2026	35.65%	0.11%	—	64.24%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	13	16	78	63	170	53	0	0	117	170
Mar 2016	14	47	60	38	160	54	5	0	100	160
Mar 2017	16	70	66	38	190	93	0	2	95	190
Mar 2018	16	88	69	54	227	102	0	0	125	227
Mar 2019	16	80	65	50	211	103	0	0	107	211
Mar 2020	16	88	52	75	231	101	1	0	128	231
Mar 2021	16	115	70	64	264	118	6	0	140	264
Mar 2022	16	135	88	90	328	135	6	0	188	328
Mar 2023	16	136	89	117	358	142	9	0	206	358
Mar 2024	16	127	107	108	357	147	8	0	202	357
Mar 2025	16	133	96	114	359	156	3	0	201	359
Mar 2026	16	87	113	92	308	148	4	0	156	308

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	14	-4	-10	1
Mar 2016	22	-11	-11	0
Mar 2017	43	-39	-3	0
Mar 2018	25	-16	-9	0
Mar 2019	22	-9	-11	1
Mar 2020	31	-7	-23	0
Mar 2021	28	-31	3	-1
Mar 2022	26	-27	3	1
Mar 2023	38	-22	-17	-1
Mar 2024	12	-18	6	0
Mar 2025	43	-19	-22	2
Mar 2026	4	-12	6	-2

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	73	37	45	61	28	52	52	38	46	28	45	63
Inventory Days	134	85	69	132	175	121	85	139	200	185	303	239
Days Payable	128	37	38	82	77	106	63	65	139	124	199	160
Cash Conversion Cycle	79	85	75	111	126	67	74	112	107	88	148	142
Working Capital Days	26	32	19	31	21	10	23	43	38	18	13	-54
ROCE %	16%	29%	31%	25%	2%	11%	27%	18%	6%	1%	8%	-14%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of MANGALAM DRUG & CHEM LTD (MANGALAM)?

The reported market capitalisation for MANGALAM DRUG & CHEM LTD (MANGALAM) is ₹49.2Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of MANGALAM?

The current price shown for MANGALAM DRUG & CHEM LTD (MANGALAM) on Fincrux is ₹31.1 with a 52-week high/low of ₹73.0/22.7.

What were MANGALAM latest quarterly results?

For Jun 2026, MANGALAM DRUG & CHEM LTD (MANGALAM) reported sales ₹57.12 Cr and net profit ₹-7.55 Cr (figures in ₹ crore unless noted).

What are MANGALAM annual sales and net profit?

For TTM, MANGALAM DRUG & CHEM LTD (MANGALAM) shows sales of ₹232 Cr and net profit of ₹-38 Cr on the Fincrux profit & loss statement.

Who owns MANGALAM DRUG & CHEM LTD (MANGALAM)?

Latest shareholding for MANGALAM DRUG & CHEM LTD (MANGALAM) on Fincrux: Promoters 35.65% (Sep 2026), FIIs 0.11% (Sep 2026), Public 64.24% (Sep 2026), No. of Shareholders 23,991% (Sep 2026).

Where can I find MANGALAM DRUG & CHEM LTD (MANGALAM) financials?

MANGALAM DRUG & CHEM LTD (MANGALAM) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show MANGALAM balance sheet and cash flow?

Yes. The MANGALAM DRUG & CHEM LTD (MANGALAM) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 1:30